Scientists have long suspected—but failed to prove—a link between certain viral infections and the development of multiple sclerosis, a crippling autoimmune disease that affects nearly 1 million Americans. Now, a study ...
Feb 9, 2022
0
1797
A new study by UCLA researchers and colleagues demonstrates that the Ebola vaccine known as rVSVΔG-ZEBOV-GP results in a robust and enduring antibody response among vaccinated individuals in areas of the Democratic Republic ...
Feb 8, 2022
1
407
If you've already had COVID-19, your natural antibodies may last as long as 20 months, a new study suggests.
Feb 7, 2022
0
384
Nearly four decades after its discovery, HIV has killed 36.3 million people, with no vaccine in sight. However, a new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, ...
Feb 4, 2022
0
180
Teams at the Institut Pasteur, CNRS, Vaccine Research Institute (VRI) and Université de Paris have discovered a new function of anti-HIV-1 antibodies by applying cutting-edge microscopy techniques to in vitro viral cultures. ...
Feb 3, 2022
0
124
The immune system develops a high-quality antibody response after three encounters with the coronavirus spike protein. These antibodies are also capable of neutralizing omicron efficiently. This applies to people who are ...
Feb 3, 2022
0
374
A new study from MIT suggests that the dozens of mutations in the spike protein of the omicron variant help it to evade all four of the classes of antibodies that can target the SARS-CoV-2 virus that causes COVID-19.
Feb 1, 2022
0
182
Researchers from North Carolina State University have discovered that a particular molecular signaling pathway plays an important role in producing osteoarthritis (OA) pain. Using a mouse model of painful osteoarthritis, ...
Jan 27, 2022
0
107
An international research collaboration has found the cancer immunotherapy treatment, pembrolizumab, can reverse HIV latency, the ability for the virus to 'hide' inside cells of people living with HIV on antiretroviral therapy, ...
Jan 26, 2022
0
128
In the journal Science, researchers from Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) and Charité–Universitätsmedizin Berlin present new findings on the immune response against the coronavirus SARS-CoV-2. ...
Jan 25, 2022
0
79
